Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2011-12-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Large Burn Outcome Study
NCT00731887
Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology
NCT05275335
Oral Care Study on Burn Patients
NCT01302457
Examine the Validity of a Panel of Objective Burn Scar Measurement Tools
NCT05126017
The Relationship of Body Function, Participation and Quality of Life in Patients With Burn: A Longitudinal Study
NCT02950675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YA Burned Subjects
Any person between the years of 19-30 years old treated for a burn injury, having incurred within past 12 months.
Questionnaire self report
Burn specific outcome measurement and global health measurement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire self report
Burn specific outcome measurement and global health measurement
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
19 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shriners Hospitals for Children
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colleen Ryan
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colleen M Ryan, MD
Role: PRINCIPAL_INVESTIGATOR
Shriners Hospitals for Children and Massachusetts General Hospital
Jeffrey Schneider, MD
Role: STUDY_DIRECTOR
Massachusetts General Hospital and Spaulding Rehab Hospital
Tina Palmieri, MD
Role: STUDY_DIRECTOR
Shriners Hospitals or Children,University of CA at Davis
David Herndon, MD
Role: STUDY_DIRECTOR
Shriners Hospitals forChildren, University of TX Medical Branch
Lewis Kazis, ScD
Role: STUDY_CHAIR
Shriners Hospitalsfor Children, Boston University School of Public Health
Ronald G Tompkins, MD
Role: STUDY_DIRECTOR
Shriners Hospitals for Children, Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shriners Hospital for Children
Sacramento, California, United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Mass General Hospital
Boston, Massachusetts, United States
Shriners Hospital for Children - Boston
Boston, Massachusetts, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Shriners Hospital for Children - Galveston
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010P002459
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.